ArticlePloS one2013
Quantifying trends in disease impact to produce a consistent and reproducible definition of an emerging infectious disease.
Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Spleen as an Alternative Tissue for Estimating Tetracapsuloides bryosalmonae Load, Prevalence and Its Relationship With Proliferative Kidney Disease in Brown Trout.Journal of fish diseases · 2026Article
- The population genetics of the causative agent of snake fungal disease indicate recent introductions to the USA.PLoS biology · 2022Article
- Cancer Trends in Iraq 2000-2016.Oman medical journal · 2021Article
- A framework for adaptive surveillance of emerging tick-borne zoonoses.One health (Amsterdam, Netherlands) · 2019Review
- "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.Journal of clinical microbiology · 2018Article
- Emergence of tick-borne diseases at northern latitudes in Europe: a comparative approach.Scientific reports · 2017Article
- Global hotspots and correlates of emerging zoonotic diseases.Nature communications · 2017Article
- Contrasting emergence of Lyme disease across ecosystems.Nature communications · 2016Article
- Quantifying Global Drivers of Zoonotic Bat Viruses: A Process-Based Perspective.The American naturalist · 2016Article
- Redefining disease emergence to improve prioritization and macro-ecological analyses.One health (Amsterdam, Netherlands) · 2015Review
- Keeping parasitology under the One Health umbrella.Trends in parasitology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The proper allocation of public health resources for research and control requires quantification of both a disease's current burden and the trend in its impact. Infectious diseases that have been labeled as "emerging infectious diseases" (EIDs) have received heightened scientific and public attention and resources. However, the label 'emerging' is rarely backed by quantitative analysis and is often used subjectively. This can lead to over-allocation of resources to diseases that are incorrectly labelled "emerging," and insufficient allocation of resources to diseases for which evidence of an increasing or high sustained impact is strong. We suggest a simple quantitative approach, segmented regression, to characterize the trends and emergence of diseases. Segmented regression identifies one or more trends in a time series and determines the most statistically parsimonious split(s) (or joinpoints) in the time series. These joinpoints in the time series indicate time points when a change in trend occurred and may identify periods in which drivers of disease impact change. We illustrate the method by analyzing temporal patterns in incidence data for twelve diseases. This approach provides a way to classify a disease as currently emerging, re-emerging, receding, or stable based on temporal trends, as well as to pinpoint the time when the change in these trends happened. We argue that quantitative approaches to defining emergence based on the trend in impact of a disease can, with appropriate context, be used to prioritize resources for research and control. Implementing this more rigorous definition of an EID will require buy-in and enforcement from scientists, policy makers, peer reviewers and journal editors, but has the potential to improve resource allocation for global health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.